Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
Vietnam · Delayed Price · Currency is VND 19,300
0.00 (0.00%)
At close: Jun 4, 2026
HNX:MKV Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
Net Income | 15,981 | 16,890 | 7,324 | 6,201 | 5,904 | 1,767 |
Depreciation & Amortization | 4,210 | 4,178 | 4,231 | 7,171 | 7,816 | 8,546 |
Loss (Gain) From Sale of Assets | -676.88 | -676.88 | - | -467.33 | -196.35 | 17,853 |
Other Operating Activities | -724.49 | 356.31 | -1,987 | 145.11 | -213.68 | -7,875 |
Change in Accounts Receivable | 19,058 | 11,945 | -5,557 | -8,042 | -3,844 | 10,585 |
Change in Inventory | -3,112 | -1,562 | -3,652 | 15,683 | 450.63 | 3,945 |
Change in Accounts Payable | -8,731 | -9,966 | 4,842 | 4,650 | -2,471 | -13,298 |
Change in Other Net Operating Assets | 117.28 | 101.34 | 395.47 | 49.34 | 145.92 | 384.62 |
Operating Cash Flow | 26,123 | 21,266 | 5,597 | 25,391 | 7,592 | 21,909 |
Operating Cash Flow Growth | 268.94% | 279.96% | -77.96% | 234.43% | -65.35% | 110.46% |
Capital Expenditures | -2,503 | -1,692 | - | -984.46 | -561.05 | - |
Sale of Property, Plant & Equipment | - | - | - | 181.82 | - | - |
Investment in Securities | 75,000 | 75,000 | - | - | - | - |
Other Investing Activities | 759.07 | 668.95 | 386.42 | 330.98 | 178.8 | 1.04 |
Investing Cash Flow | -30,244 | -22,023 | 386.42 | -471.66 | -382.25 | 1.04 |
Short-Term Debt Issued | - | - | 5,010 | 9,087 | 50,133 | - |
Long-Term Debt Issued | - | - | - | - | - | 64,019 |
Total Debt Issued | - | - | 5,010 | 9,087 | 50,133 | 64,019 |
Short-Term Debt Repaid | - | - | -5,010 | -27,492 | -56,235 | - |
Long-Term Debt Repaid | - | - | - | - | - | -85,126 |
Total Debt Repaid | - | - | -5,010 | -27,492 | -56,235 | -85,126 |
Net Debt Issued (Repaid) | - | - | - | -18,405 | -6,102 | -21,107 |
Common Dividends Paid | - | - | - | -1,500 | - | - |
Financing Cash Flow | - | - | - | -19,905 | -6,102 | -21,107 |
Net Cash Flow | -4,121 | -757.57 | 5,983 | 5,014 | 1,108 | 802.87 |
Free Cash Flow | 23,620 | 19,573 | 5,597 | 24,406 | 7,031 | 21,909 |
Free Cash Flow Growth | 233.59% | 249.72% | -77.07% | 247.11% | -67.91% | 193.49% |
Free Cash Flow Margin | 15.50% | 13.07% | 5.23% | 22.01% | 5.88% | 21.39% |
Free Cash Flow Per Share | 4724.03 | 3914.70 | 1119.37 | 4881.24 | 1406.48 | - |
Cash Interest Paid | - | - | 38.53 | 577.22 | 1,157 | 3,830 |
Cash Income Tax Paid | 4,357 | 3,867 | 3,431 | 1,300 | 1,475 | 1,040 |
Levered Free Cash Flow | 12,313 | 8,179 | 6,521 | 26,537 | - | 14,676 |
Unlevered Free Cash Flow | 12,313 | 8,179 | 6,546 | 26,838 | - | 17,108 |
Change in Working Capital | 7,333 | 518.41 | -3,971 | 12,341 | -5,718 | 1,617 |